Advertisement

Ads Placeholder
Loading...

Dr. Lal PathLabs Limited

LALPATHLAB.BO•BSE
Healthcare
Medical - Diagnostics & Research
₹1329.30
₹9.35(0.71%)
Indian Market opens in 34h 10m

Dr. Lal PathLabs Limited (LALPATHLAB.BO) Stock Overview

Explore Dr. Lal PathLabs Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap222B
P/E Ratio42.02
EPS (TTM)$31.66
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$1502.61
3 Months$2487.21
1 Year Target$2342.08

LALPATHLAB.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dr. Lal PathLabs Limited (LALPATHLAB.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2342.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.02 and a market capitalization of 222B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.71%
5-Day Change
0.33%
1-Month Change
-2.19%
3-Month Change
-9.75%
6-Month Change
-14.94%
Year-to-Date (YTD) Change
-11.90%
1-Year Change
5.74%
3-Year Change
44.42%
5-Year Change
-8.26%
All-Time (Max) Change
222.58%

Contact Information

https://www.lalpathlabs.com
91 12 4301 6500
Tower B, SAS Tower, Gurugram, NaN, 122001

Company Facts

40,990 Employees
IPO DateDec 23, 2015
CountryIN
Actively Trading

Frequently Asked Questions